Shares of micro-cap Obalon Therapeutics OBLN traded higher after traders circulated the U.S. patent and trademark office abstract for its Intragastric device.
The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.
Obalon Therapeutics shares traded higher by 6% at 80 cents on Tuesday afternoon.
Related Links:
Premarket Approval Doc For Balloon System Sends Obalon Shares Sharply Higher
Obalon Closes Above $1 Following Questionable Takeover Rumor
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
